Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Physiological Assessment and fMRI in a Case of Posthypoxic Myoclonus
Movement Disorders
(-)
170
Authors/Disclosures
Neekita Jikaria No disclosure on file
No disclosure on file
No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (University of Pennsylvania) Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
No disclosure on file
No disclosure on file
Guy A. Rouleau, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Montreal Neurological Institute and Hospital) Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Guy A. Rouleau, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Montreal Neurological Institute and Hospital) Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
L. C. Turtzo, MD, PhD (NIH / NINDS) No disclosure on file
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
No disclosure on file